NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: Implications for Huntington's disease

Maddalena Napolitano, Daniela Zei, Diego Centonze, Rocco Palermo, Giorgio Bernardi, Alessandra Vacca, Paolo Calabresi, Alberto Gulino

Research output: Contribution to journalArticlepeer-review


Nuclear factor-kB (NF-kB) is a family of DNA-binding proteins that are important regulators involved in immune and inflammatory responses, as well as in cell survival and apoptosis. In the nervous system NF-kB is activated under physiological and pathological conditions including learning and memory mechanisms and neurodegenerative diseases. NF-kB is activated in neurons in response to excitotoxic, metabolic and oxidative stress and there is a body of evidence to suggest that glutamate induces NF-kB by the main ionotropic glutamate receptors. In the present study, 3 nitroproprionic acid (3NP), an irreversible inhibitor of succinate dehydrogenase (SD, complex II) has been employed to provide an experimental model of Huntington's disease (HD). Specifically, we described 3NP-induced activation of NF-kB and of iNOS and nNOS genes in striatal treated slices. To aim to better understand the relationship between these identified dysregulated genes and mitochondrial dysfunction, we investigated in SK-N-MC human neuroblastoma cells following 3NP treatment, whether NF-kB nuclear translocation and activation might be involved in the mechanisms by which 3NP leads to transcriptional activation of NOS genes. These results are relevant to more precisely define the role of NF-kB in neuronal cells and better understand its putative involvement in neurodegeneration.

Original languageEnglish
Pages (from-to)241-246
Number of pages6
JournalNeuroscience Letters
Issue number3
Publication statusPublished - Apr 4 2008


  • 3-nitropropionic acid
  • Basal ganglia
  • Huntington's disease
  • NF-kB
  • NOS

ASJC Scopus subject areas

  • Neuroscience(all)


Dive into the research topics of 'NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: Implications for Huntington's disease'. Together they form a unique fingerprint.

Cite this